share_log

Needham Maintains Buy on Cardlytics, Lowers Price Target to $12

Benzinga ·  Nov 9, 2023 08:27

Needham analyst Kyle Peterson maintains Cardlytics (NASDAQ:CDLX) with a Buy and lowers the price target from $19 to $12.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment